Rojas-Caro Sandra 4
4 · NeuBase Therapeutics, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Rojas-Caro Sandra
Chief Medical Officer
Transactions
- Award
Employee stock option (right to buy)
2022-01-24+44,592→ 44,592 totalExercise: $1.58Exp: 2032-01-24→ Common stock (44,592 underlying)
Footnotes (1)
- [F1]1/4th of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.